SLC2A4 and Hyperglycemia: Excess FFAs generate diacylglycerol and ceramides that activate novel protein kinase C (PKC) isoforms, disrupt IR/IRS phosphorylation, and impair GLUT4 translocation, producing metabolic inflexibility with reduced glucose uptake and sustained hyperglycemia (65, 66).